drugset / Trial / NCT00960453

Clinical Trial to Investigate the Pharmacokinetics/Pharmacodynamics of Sitagliptin

NCT00960453

Phase 1 Completed 12 enrolled Seoul National University Hospital
RandomizedCrossoverOpen-label

Summary

The purpose of this study is to investigate the pharmacokinetics and pharmacodynamics of sitagliptin in healthy volunteers.

Timeline

Start
2008-12
Primary completion
2009-09
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Sitagliptin Small molecule 25 mg
Subject Sitagliptin Small molecule 50 mg
Subject Sitagliptin Small molecule 100 mg

Indications